⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATRA News
Atara Biotherapeutics, Inc
Pomerantz LLP Announces The Filing of a Class Action Lawsuit Against Atara Biotherapeutics, Inc. – ATRA
accessnewswire.com
ATRA
Pomerantz LLP Announces Securities Class Action Lawsuit Against Atara Biotherapeutics, Inc. – ATRA
accessnewswire.com
ATRA
ATRA INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026 Ready to Announce with Confidence?
newsfilecorp.com
ATRA
ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Atara Biotherapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
ATRA
Pomerantz LLP Announces The Filing of a Class Action Against Atara Biotherapeutics, Inc. – ATRA
accessnewswire.com
ATRA
Pomerantz LLP Announces Securities Class Action Against Atara Biotherapeutics, Inc. – ATRA
accessnewswire.com
ATRA
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit
prnewswire.com
ATRA
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATRA
globenewswire.com
ATRA
ATRA SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Atara Biotherapeutics, Inc. Investors - Contact Kirby McInerney LLP by May 22, 2026
globenewswire.com
ATRA
Pomerantz LLP Announces Securities Class Action Litigation Against Atara Biotherapeutics, Inc. – ATRA
accessnewswire.com
ATRA